3-127660633-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015720.4(PODXL2):āc.605A>Gā(p.Gln202Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000473 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015720.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PODXL2 | NM_015720.4 | c.605A>G | p.Gln202Arg | missense_variant | 3/8 | ENST00000342480.7 | NP_056535.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PODXL2 | ENST00000342480.7 | c.605A>G | p.Gln202Arg | missense_variant | 3/8 | 1 | NM_015720.4 | ENSP00000345359.6 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000394 AC: 99AN: 251434Hom.: 0 AF XY: 0.000383 AC XY: 52AN XY: 135900
GnomAD4 exome AF: 0.000490 AC: 717AN: 1461894Hom.: 0 Cov.: 34 AF XY: 0.000492 AC XY: 358AN XY: 727248
GnomAD4 genome AF: 0.000302 AC: 46AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.605A>G (p.Q202R) alteration is located in exon 3 (coding exon 3) of the PODXL2 gene. This alteration results from a A to G substitution at nucleotide position 605, causing the glutamine (Q) at amino acid position 202 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at